Brief: Regenxbio Q1 Net Income USD 6.083 Million
12/05/2025 21:11
May 12 (Reuters) - Regenxbio Inc RGNX.O: REGENXBIO Q1 NET INCOME USD 6.083 MILLION REGENXBIO Q1 OPERATING EXPENSES USD 76.885 MILLION REGENXBIO Q1 LICENSE & ROYALTY REVENUE USD 87.049 MILLION REGENXBIO INC: EXPECTS BALANCE OF $272.7 MILLION AS OF MARCH 31, 2025 TO FUND ITS OPERATIONS INTO H2 2026 Source text: ID:nPn2gDzcpa Further company coverage: RGNX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics